Position in AZN
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$1,327
New position
Shares Held
7
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,447
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Noble Wealth Management PBC holds $799,244 across 11 Drug Manufacturers - General names. AZN ranks #5 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
603 | $723,256 | |
| 2 | MRK |
Merck & Co., Inc.
|
274 | $35,209 | |
| 3 | JNJ |
Johnson & Johnson
|
124 | $31,492 | |
| 4 | ABBV |
AbbVie Inc.
|
7 | $1,761 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
7 | $1,327 | |
| 6 | NVS |
Novartis AG
|
8 | $1,253 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9 | $1,137 | |
| 8 | AMGN |
Amgen Inc
|
3 | $1,086 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,327 | 7 | Shares | Sole | 2026-07-01 | |
| No filing history on record for this holder in this stock. | ||||||